HEADER LYASE 06-MAY-12 4F13 TITLE ALGINATE LYASE A1-III Y246F COMPLEXED WITH TETRASACCHARIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALGINATE LYASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 54-404; COMPND 5 SYNONYM: ALGINATE LYASE A1-III; COMPND 6 EC: 4.2.2.3; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SPHINGOMONAS; SOURCE 3 ORGANISM_TAXID: 28214; SOURCE 4 STRAIN: A1; SOURCE 5 GENE: ALY; SOURCE 6 EXPRESSION_SYSTEM: BACILLUS SUBTILIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1423; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PISA412 KEYWDS ALPHA BARREL, POLYSACCHARIDE LYASE, ALGINATE, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR B.MIKAMI,M.BAN,S.SUZUKI,H.-J.YOON,O.MIYAKE,M.YAMASAKI,K.OGURA, AUTHOR 2 Y.MARUYAMA,W.HASHIMOTO,K.MURATA REVDAT 4 08-NOV-23 4F13 1 HETSYN REVDAT 3 29-JUL-20 4F13 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 26-SEP-12 4F13 1 JRNL REVDAT 1 27-JUN-12 4F13 0 SPRSDE 27-JUN-12 4F13 4E25 JRNL AUTH B.MIKAMI,M.BAN,S.SUZUKI,H.-J.YOON,O.MIYAKE,M.YAMASAKI, JRNL AUTH 2 K.OGURA,Y.MARUYAMA,W.HASHIMOTO,K.MURATA JRNL TITL INDUCED-FIT MOTION OF A LID LOOP INVOLVED IN CATALYSIS IN JRNL TITL 2 ALGINATE LYASE A1-III JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 68 1207 2012 JRNL REFN ISSN 0907-4449 JRNL PMID 22948922 JRNL DOI 10.1107/S090744491202495X REMARK 2 REMARK 2 RESOLUTION. 2.21 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.21 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.73 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 36472 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1835 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.7451 - 5.1907 1.00 2973 158 0.1561 0.1792 REMARK 3 2 5.1907 - 4.1207 1.00 2818 161 0.1327 0.1515 REMARK 3 3 4.1207 - 3.6000 0.98 2757 157 0.1395 0.1754 REMARK 3 4 3.6000 - 3.2709 0.96 2693 123 0.1671 0.2106 REMARK 3 5 3.2709 - 3.0365 0.95 2655 145 0.1864 0.2144 REMARK 3 6 3.0365 - 2.8575 0.96 2624 138 0.1936 0.2402 REMARK 3 7 2.8575 - 2.7144 0.95 2612 145 0.2134 0.2812 REMARK 3 8 2.7144 - 2.5963 0.95 2627 122 0.2173 0.2313 REMARK 3 9 2.5963 - 2.4963 0.95 2576 153 0.2130 0.3135 REMARK 3 10 2.4963 - 2.4102 0.95 2624 136 0.2215 0.2235 REMARK 3 11 2.4102 - 2.3348 0.95 2615 134 0.2298 0.3065 REMARK 3 12 2.3348 - 2.2681 0.95 2591 132 0.2355 0.3038 REMARK 3 13 2.2681 - 2.2084 0.91 2472 131 0.2482 0.3273 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 53.02 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.76950 REMARK 3 B22 (A**2) : 1.34120 REMARK 3 B33 (A**2) : 1.42830 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 5871 REMARK 3 ANGLE : 1.305 7991 REMARK 3 CHIRALITY : 0.085 857 REMARK 3 PLANARITY : 0.006 1045 REMARK 3 DIHEDRAL : 19.555 2216 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 2 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND (RESSEQ 5:9 OR RESSEQ 11:13 REMARK 3 OR RESSEQ 15:31 OR RESSEQ 35:60 OR RESSEQ REMARK 3 86:157 OR RESSEQ 159:168 OR RESSEQ 170: REMARK 3 208 OR RESSEQ 212:296 OR RESSEQ 298:352 ) REMARK 3 SELECTION : CHAIN B AND (RESSEQ 5:9 OR RESSEQ 11:13 REMARK 3 OR RESSEQ 15:31 OR RESSEQ 35:60 OR RESSEQ REMARK 3 86:157 OR RESSEQ 159:168 OR RESSEQ 170: REMARK 3 208 OR RESSEQ 212:296 OR RESSEQ 298:352 ) REMARK 3 ATOM PAIRS NUMBER : 2424 REMARK 3 RMSD : 0.082 REMARK 3 NCS GROUP : 2 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A AND (RESSEQ 402:403 ) REMARK 3 SELECTION : CHAIN B AND (RESSEQ 401:402 ) REMARK 3 ATOM PAIRS NUMBER : 24 REMARK 3 RMSD : 0.200 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4F13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072321. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL38B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36529 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 48.733 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 5.390 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.48400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB 4E1Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24%(W/V) PEG4000, 0.3M AMMONIUM REMARK 280 ACETATE, 0.1M SODIUM CITRATE, PH 5.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.78550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.83900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.78000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.83900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.78550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.78000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 4 REMARK 465 GLY B 4 REMARK 465 LEU B 69 REMARK 465 SER B 70 REMARK 465 GLY B 71 REMARK 465 ASN B 72 REMARK 465 HIS B 73 REMARK 465 GLY B 74 REMARK 465 PRO B 75 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 19 -154.71 57.16 REMARK 500 ASN A 158 58.69 -93.11 REMARK 500 CYS A 189 -9.14 -140.10 REMARK 500 ASN A 190 -157.77 -97.06 REMARK 500 HIS A 240 -124.25 60.39 REMARK 500 PHE A 327 173.65 -56.93 REMARK 500 THR A 335 -71.86 -105.44 REMARK 500 SER B 19 -155.13 57.59 REMARK 500 ASP B 22 95.28 -63.80 REMARK 500 GLN B 34 78.51 -116.33 REMARK 500 ASN B 190 -157.70 -94.68 REMARK 500 HIS B 240 -122.77 58.60 REMARK 500 PHE B 327 172.97 -58.04 REMARK 500 THR B 335 -70.60 -102.14 REMARK 500 ALA B 351 -37.13 -130.56 REMARK 500 GLN B 355 91.06 -68.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4E1Y RELATED DB: PDB REMARK 900 H192A APO FORM REMARK 900 RELATED ID: 4F10 RELATED DB: PDB REMARK 900 H192A/TETRASACCHARIDE COMPLEX DBREF 4F13 A 6 356 UNP Q9KWU1 Q9KWU1_SPHSX 54 404 DBREF 4F13 B 6 356 UNP Q9KWU1 Q9KWU1_SPHSX 54 404 SEQADV 4F13 GLY A 4 UNP Q9KWU1 EXPRESSION TAG SEQADV 4F13 SER A 5 UNP Q9KWU1 EXPRESSION TAG SEQADV 4F13 PHE A 246 UNP Q9KWU1 TYR 294 ENGINEERED MUTATION SEQADV 4F13 ALA A 347 UNP Q9KWU1 GLY 395 CONFLICT SEQADV 4F13 GLY B 4 UNP Q9KWU1 EXPRESSION TAG SEQADV 4F13 SER B 5 UNP Q9KWU1 EXPRESSION TAG SEQADV 4F13 PHE B 246 UNP Q9KWU1 TYR 294 ENGINEERED MUTATION SEQADV 4F13 ALA B 347 UNP Q9KWU1 GLY 395 CONFLICT SEQRES 1 A 353 GLY SER HIS PRO PHE ASP GLN ALA VAL VAL LYS ASP PRO SEQRES 2 A 353 THR ALA SER TYR VAL ASP VAL LYS ALA ARG ARG THR PHE SEQRES 3 A 353 LEU GLN SER GLY GLN LEU ASP ASP ARG LEU LYS ALA ALA SEQRES 4 A 353 LEU PRO LYS GLU TYR ASP CYS THR THR GLU ALA THR PRO SEQRES 5 A 353 ASN PRO GLN GLN GLY GLU MET VAL ILE PRO ARG ARG TYR SEQRES 6 A 353 LEU SER GLY ASN HIS GLY PRO VAL ASN PRO ASP TYR GLU SEQRES 7 A 353 PRO VAL VAL THR LEU TYR ARG ASP PHE GLU LYS ILE SER SEQRES 8 A 353 ALA THR LEU GLY ASN LEU TYR VAL ALA THR GLY LYS PRO SEQRES 9 A 353 VAL TYR ALA THR CYS LEU LEU ASN MET LEU ASP LYS TRP SEQRES 10 A 353 ALA LYS ALA ASP ALA LEU LEU ASN TYR ASP PRO LYS SER SEQRES 11 A 353 GLN SER TRP TYR GLN VAL GLU TRP SER ALA ALA THR ALA SEQRES 12 A 353 ALA PHE ALA LEU SER THR MET MET ALA GLU PRO ASN VAL SEQRES 13 A 353 ASP THR ALA GLN ARG GLU ARG VAL VAL LYS TRP LEU ASN SEQRES 14 A 353 ARG VAL ALA ARG HIS GLN THR SER PHE PRO GLY GLY ASP SEQRES 15 A 353 THR SER CYS CYS ASN ASN HIS SER TYR TRP ARG GLY GLN SEQRES 16 A 353 GLU ALA THR ILE ILE GLY VAL ILE SER LYS ASP ASP GLU SEQRES 17 A 353 LEU PHE ARG TRP GLY LEU GLY ARG TYR VAL GLN ALA MET SEQRES 18 A 353 GLY LEU ILE ASN GLU ASP GLY SER PHE VAL HIS GLU MET SEQRES 19 A 353 THR ARG HIS GLU GLN SER LEU HIS PHE GLN ASN TYR ALA SEQRES 20 A 353 MET LEU PRO LEU THR MET ILE ALA GLU THR ALA SER ARG SEQRES 21 A 353 GLN GLY ILE ASP LEU TYR ALA TYR LYS GLU ASN GLY ARG SEQRES 22 A 353 ASP ILE HIS SER ALA ARG LYS PHE VAL PHE ALA ALA VAL SEQRES 23 A 353 LYS ASN PRO ASP LEU ILE LYS LYS TYR ALA SER GLU PRO SEQRES 24 A 353 GLN ASP THR ARG ALA PHE LYS PRO GLY ARG GLY ASP LEU SEQRES 25 A 353 ASN TRP ILE GLU TYR GLN ARG ALA ARG PHE GLY PHE ALA SEQRES 26 A 353 ASP GLU LEU GLY PHE MET THR VAL PRO ILE PHE ASP PRO SEQRES 27 A 353 ARG THR GLY GLY SER ALA THR LEU LEU ALA TYR LYS PRO SEQRES 28 A 353 GLN GLY SEQRES 1 B 353 GLY SER HIS PRO PHE ASP GLN ALA VAL VAL LYS ASP PRO SEQRES 2 B 353 THR ALA SER TYR VAL ASP VAL LYS ALA ARG ARG THR PHE SEQRES 3 B 353 LEU GLN SER GLY GLN LEU ASP ASP ARG LEU LYS ALA ALA SEQRES 4 B 353 LEU PRO LYS GLU TYR ASP CYS THR THR GLU ALA THR PRO SEQRES 5 B 353 ASN PRO GLN GLN GLY GLU MET VAL ILE PRO ARG ARG TYR SEQRES 6 B 353 LEU SER GLY ASN HIS GLY PRO VAL ASN PRO ASP TYR GLU SEQRES 7 B 353 PRO VAL VAL THR LEU TYR ARG ASP PHE GLU LYS ILE SER SEQRES 8 B 353 ALA THR LEU GLY ASN LEU TYR VAL ALA THR GLY LYS PRO SEQRES 9 B 353 VAL TYR ALA THR CYS LEU LEU ASN MET LEU ASP LYS TRP SEQRES 10 B 353 ALA LYS ALA ASP ALA LEU LEU ASN TYR ASP PRO LYS SER SEQRES 11 B 353 GLN SER TRP TYR GLN VAL GLU TRP SER ALA ALA THR ALA SEQRES 12 B 353 ALA PHE ALA LEU SER THR MET MET ALA GLU PRO ASN VAL SEQRES 13 B 353 ASP THR ALA GLN ARG GLU ARG VAL VAL LYS TRP LEU ASN SEQRES 14 B 353 ARG VAL ALA ARG HIS GLN THR SER PHE PRO GLY GLY ASP SEQRES 15 B 353 THR SER CYS CYS ASN ASN HIS SER TYR TRP ARG GLY GLN SEQRES 16 B 353 GLU ALA THR ILE ILE GLY VAL ILE SER LYS ASP ASP GLU SEQRES 17 B 353 LEU PHE ARG TRP GLY LEU GLY ARG TYR VAL GLN ALA MET SEQRES 18 B 353 GLY LEU ILE ASN GLU ASP GLY SER PHE VAL HIS GLU MET SEQRES 19 B 353 THR ARG HIS GLU GLN SER LEU HIS PHE GLN ASN TYR ALA SEQRES 20 B 353 MET LEU PRO LEU THR MET ILE ALA GLU THR ALA SER ARG SEQRES 21 B 353 GLN GLY ILE ASP LEU TYR ALA TYR LYS GLU ASN GLY ARG SEQRES 22 B 353 ASP ILE HIS SER ALA ARG LYS PHE VAL PHE ALA ALA VAL SEQRES 23 B 353 LYS ASN PRO ASP LEU ILE LYS LYS TYR ALA SER GLU PRO SEQRES 24 B 353 GLN ASP THR ARG ALA PHE LYS PRO GLY ARG GLY ASP LEU SEQRES 25 B 353 ASN TRP ILE GLU TYR GLN ARG ALA ARG PHE GLY PHE ALA SEQRES 26 B 353 ASP GLU LEU GLY PHE MET THR VAL PRO ILE PHE ASP PRO SEQRES 27 B 353 ARG THR GLY GLY SER ALA THR LEU LEU ALA TYR LYS PRO SEQRES 28 B 353 GLN GLY HET BEM C 1 13 HET BEM C 2 12 HET BEM C 3 12 HET MAW C 4 11 HET BEM D 1 13 HET BEM D 2 12 HETNAM BEM BETA-D-MANNOPYRANURONIC ACID HETNAM MAW 4-DEOXY-ALPHA-L-ERYTHRO-HEX-4-ENOPYRANURONIC ACID HETSYN BEM BETA-D-MANNURONIC ACID; D-MANNURONIC ACID; MANNURONIC HETSYN 2 BEM ACID; (2S,3S,4S,5S,6R)-3,4,5,6-TETRAHYDROXYOXANE-2- HETSYN 3 BEM CARBOXYLIC ACID HETSYN MAW 4-DEOXY-ALPHA-L-ERYTHRO-HEX-4-ENURONIC ACID; 4-DEOXY-L- HETSYN 2 MAW ERYTHRO-HEX-4-ENURONIC ACID; 4-DEOXY-ERYTHRO-HEX-4- HETSYN 3 MAW ENURONIC ACID FORMUL 3 BEM 5(C6 H10 O7) FORMUL 3 MAW C6 H8 O6 FORMUL 5 HOH *269(H2 O) HELIX 1 1 ASP A 22 GLY A 33 1 12 HELIX 2 2 ASP A 36 LEU A 43 1 8 HELIX 3 3 ASP A 48 GLU A 52 5 5 HELIX 4 4 ASP A 79 GLY A 105 1 27 HELIX 5 5 LYS A 106 ALA A 123 1 18 HELIX 6 6 SER A 133 SER A 151 1 19 HELIX 7 7 THR A 152 MET A 154 5 3 HELIX 8 8 ASP A 160 SER A 180 1 21 HELIX 9 9 ASN A 190 SER A 207 1 18 HELIX 10 10 ASP A 209 GLY A 225 1 17 HELIX 11 11 PHE A 233 GLU A 241 5 9 HELIX 12 12 GLN A 242 ARG A 263 1 22 HELIX 13 13 ASP A 267 TYR A 271 5 5 HELIX 14 14 ASP A 277 ASN A 291 1 15 HELIX 15 15 PRO A 292 LYS A 297 1 6 HELIX 16 16 ARG A 312 ASP A 314 5 3 HELIX 17 17 LEU A 315 GLY A 326 1 12 HELIX 18 18 ASP A 340 GLY A 344 5 5 HELIX 19 19 SER A 346 TYR A 352 1 7 HELIX 20 20 ASP B 22 SER B 32 1 11 HELIX 21 21 ASP B 36 LEU B 43 1 8 HELIX 22 22 ASP B 48 GLU B 52 5 5 HELIX 23 23 ASP B 79 GLY B 105 1 27 HELIX 24 24 LYS B 106 ALA B 123 1 18 HELIX 25 25 SER B 133 SER B 151 1 19 HELIX 26 26 THR B 152 MET B 154 5 3 HELIX 27 27 ASP B 160 THR B 179 1 20 HELIX 28 28 ASN B 190 SER B 207 1 18 HELIX 29 29 ASP B 209 GLY B 225 1 17 HELIX 30 30 PHE B 233 GLU B 241 5 9 HELIX 31 31 GLN B 242 ARG B 263 1 22 HELIX 32 32 ASP B 267 TYR B 271 5 5 HELIX 33 33 ASP B 277 ASN B 291 1 15 HELIX 34 34 PRO B 292 LYS B 297 1 6 HELIX 35 35 ARG B 312 ASP B 314 5 3 HELIX 36 36 LEU B 315 GLY B 326 1 12 HELIX 37 37 ASP B 340 GLY B 344 5 5 HELIX 38 38 SER B 346 TYR B 352 1 7 SSBOND 1 CYS A 49 CYS A 112 1555 1555 2.02 SSBOND 2 CYS A 188 CYS A 189 1555 1555 2.04 SSBOND 3 CYS B 49 CYS B 112 1555 1555 2.03 SSBOND 4 CYS B 188 CYS B 189 1555 1555 2.03 LINK O4 BEM C 1 C1 BEM C 2 1555 1555 1.41 LINK O4 BEM C 2 C1 BEM C 3 1555 1555 1.41 LINK O4 BEM C 3 C1 MAW C 4 1555 1555 1.41 LINK O4 BEM D 1 C1 BEM D 2 1555 1555 1.41 CRYST1 65.571 77.560 145.678 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015251 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012893 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006864 0.00000